Literature DB >> 18056000

Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum.

Anne L Morkbak1, Anne-Mette Hvas, Nils Milman, Ebba Nexo.   

Abstract

We confirm a decrease in cobalamins during pregnancy, and report that the active part of cobalamins (holotranscobalamin, holoTC) remains unchanged. The decrease in cobalamins is explained by a decreased holohaptocorrin (holoHC), suggesting that holoTC rather than cobalamins should be used as a marker of vitamin B12 deficiency during pregnancy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18056000     DOI： 10.3324/haematol.11636

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  16 in total

Review 1.  Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review.

Authors:  Lindsay H Allen; Joshua W Miller; Lisette de Groot; Irwin H Rosenberg; A David Smith; Helga Refsum; Daniel J Raiten
Journal:  J Nutr       Date:  2018-12-01       Impact factor: 4.798

2.  Association between Maternal and Infantile Markers of Cobalamin Status During the First Month Post-Delivery.

Authors:  Sümeyra Çoban; Ebru Yılmaz Keskin; Mahir İğde
Journal:  Indian J Pediatr       Date:  2018-01-06       Impact factor: 1.967

3.  To vegan or not to vegan when pregnant, lactating or feeding young children.

Authors:  R Pawlak
Journal:  Eur J Clin Nutr       Date:  2017-07-26       Impact factor: 4.016

Review 4.  Cobalamin Status from Pregnancy to Early Childhood: Lessons from Global Experience.

Authors:  Rima Obeid; Michelle Murphy; Pol Solé-Navais; Chittaranjan Yajnik
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

Review 5.  Vitamin B-12 and Perinatal Health.

Authors:  Julia L Finkelstein; Alexander J Layden; Patrick J Stover
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

6.  A longitudinal study of maternal folate and vitamin B12 status in pregnancy and postpartum, with the same infant markers at 6 months of age.

Authors:  Alexis J Hure; Clare E Collins; Roger Smith
Journal:  Matern Child Health J       Date:  2012-05

7.  Assessment of the vitamin B12 status of pregnant women in Nigeria using plasma holotranscobalamin.

Authors:  Dorothy J Vanderjagt; Innocent A O Ujah; Eugene I Ikeh; Jessica Bryant; Victor Pam; Amelia Hilgart; Michael J Crossey; Robert H Glew
Journal:  ISRN Obstet Gynecol       Date:  2011-07-14

Review 8.  Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II.

Authors:  Ralph Carmel
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

Review 9.  Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility.

Authors:  Ebba Nexo; Elke Hoffmann-Lücke
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

10.  Vitamin B-12 status during pregnancy and child's IQ at age 8: a Mendelian randomization study in the Avon longitudinal study of parents and children.

Authors:  Carolina Bonilla; Debbie A Lawlor; Amy E Taylor; David J Gunnell; Yoav Ben-Shlomo; Andrew R Ness; Nicholas J Timpson; Beate St Pourcain; Susan M Ring; Pauline M Emmett; A David Smith; Helga Refsum; Craig E Pennell; Marie-Jo Brion; George Davey Smith; Sarah J Lewis
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.